Holen Sie sich die Stockscreener-App
34.02
2.24%
-0.69
Schlusskurs vom Vortag:
$34.71
Offen:
$34.63
24-Stunden-Volumen:
628.76K
Relative Volume:
0.45
Marktkapitalisierung:
$1.90B
Einnahmen:
$249.12M
Nettoeinkommen (Verlust:
$-90.19M
KGV:
-20.01
EPS:
-1.7
Netto-Cashflow:
$-88.21M
1W Leistung:
+7.86%
1M Leistung:
-5.37%
6M Leistung:
-40.44%
1J Leistung:
-61.23%
1-Tages-Spanne:
$33.68
$34.67
1-Wochen-Bereich:
$30.60
$35.40
52-Wochen-Spanne:
$27.80
$88.00
Procept Biorobotics Corp Stock (PRCT) Company Profile
Firmenname
Procept Biorobotics Corp
Sektor
Branche
Telefon
(650) 232-9832
Adresse
150 BAYTECH DRIVE, SAN JOSE
Vergleichen Sie PRCT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
33.95 | 1.94B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
126.98 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.60 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.11 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.45 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.56 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-12 | Eingeleitet | UBS | Buy |
| 2025-12-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-09-02 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-07-09 | Eingeleitet | Stephens | Overweight |
| 2025-07-07 | Eingeleitet | Oppenheimer | Perform |
| 2024-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Eingeleitet | Jefferies | Hold |
| 2023-08-11 | Eingeleitet | Piper Sandler | Overweight |
| 2023-05-31 | Eingeleitet | William Blair | Outperform |
| 2022-10-31 | Eingeleitet | BTIG Research | Neutral |
| 2022-10-25 | Eingeleitet | Truist | Buy |
| 2022-09-02 | Eingeleitet | Wells Fargo | Overweight |
| 2022-07-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-10-11 | Eingeleitet | Cowen | Outperform |
| 2021-10-11 | Eingeleitet | Goldman | Neutral |
| 2021-10-11 | Eingeleitet | Guggenheim | Buy |
| 2021-10-11 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Procept Biorobotics Corp Aktie (PRCT) Neueste Nachrichten
PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: A 53% Potential Upside in the Surgical Robotics Arena - DirectorsTalk Interviews
How Investors Are Reacting To PROCEPT BioRobotics (PRCT) UBS Coverage Initiation And 2027 Profitability Outlook - simplywall.st
What Wall Street predicts for PROCEPT BioRobotics Corporation stock priceConsumer Goods Stocks & Free Record-Breaking Gains - Bollywood Helpline
Promising Growth Forecasts Leading to Analysts' Optimism for Procept Biorobotics (PRCT) - Finviz
Promising growth forecasts leading to analysts’ optimism for Procept Biorobotics (PRCT) - MSN
Promising Growth Forecasts Leading to Analysts’ Optimism for Procept Biorobotics (PRCT) - Yahoo Finance
15 Most Promising Mid-Cap Healthcare Stocks Under $50 - Insider Monkey
Aug EndMonth: What Wall Street predicts for PROCEPT BioRobotics Corporation stock priceJuly 2025 Gainers & AI Driven Stock Movement Reports - Улправда
Transcript : PROCEPT BioRobotics Corporation Presents at Piper Sandler 37th Annual Healthcare Conference, Dec-02-2025 08 - marketscreener.com
Will PROCEPT BioRobotics Corporation stock outperform value stocksMarket Risk Summary & Technical Pattern Alert System - DonanımHaber
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Procept BioRobotics price target lowered to $47 from $50 at Truist - TipRanks
Truist Financial Has Lowered Expectations for PROCEPT BioRobotics (NASDAQ:PRCT) Stock Price - MarketBeat
Truist Financial Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Cuts Target Price to $47 - 富途牛牛
Truist Securities Adjusts Price Target on PROCEPT BioRobotics to $47 From $50, Maintains Buy Rating - marketscreener.com
Procept BioRobotics initiated with a buy at UBS - MSN
PROCEPT BioRobotics (PRCT) Stock Analysis: Eyeing a 41% Upside with Robust Revenue Growth - DirectorsTalk Interviews
3 Underrated Robotics Stocks Poised for Huge Gains - Investing.com
PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Shareholders Might Be Looking For Exit - 富途牛牛
Squarepoint Ops LLC Decreases Stake in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Downgraded by Wall Street Zen to Sell - MarketBeat
PROCEPT BioRobotics Corporation $PRCT Shares Bought by Eventide Asset Management LLC - MarketBeat
Bellevue Group AG Acquires 74,355 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
UBS Initiates Coverage of PROCEPT BioRobotics (PRCT) with Buy Recommendation - Nasdaq
UBS initiates Procept BioRobotics stock with Buy rating on utilization growth - Investing.com Australia
PRCT FinancialsIncome Statement - Quiver Quantitative
Procept BioRobotics initiated with a Buy at UBS - TipRanks
UBS Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Raises Target Price to $62 - 富途牛牛
Promising Growth and Investment Opportunity for PROCEPT BioRobotics: Analyst Buy Rating - TipRanks
Frontier Capital Management Co. LLC Acquires 203,602 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
UBS initiates Procept BioRobotics stock with Buy rating on utilization growth By Investing.com - Investing.com South Africa
PROCEPT BioRobotics (PRCT): Reassessing Valuation After BofA Downgrade and Slower Aquablation Growth Concerns - simplywall.st
Axa S.A. Purchases 63,519 Shares of PROCEPT BioRobotics Corporation $PRCT - Defense World
Next Century Growth Investors LLC Buys 62,112 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Federated Hermes Inc. Acquires 25,863 Shares of PROCEPT BioRobotics Corporation $PRCT - Defense World
Does PROCEPT BioRobotics (PRCT) Slower Aquablation Uptake Recast Its Long-Term Market Penetration Story? - Yahoo Finance
Does Slower Aquablation Growth at PROCEPT (PRCT) Hint At A Transition In Its Long-Term Story? - Sahm
PROCEPT BioRobotics Faces Slower Growth As BofA Lowers Rating - Finimize
PROCEPT BioRobotics’ (PRCT) “Neutral” Rating Reaffirmed at Bank of America - Defense World
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Gap DownHere's Why - MarketBeat
PROCEPT BioRobotics has Large Market Opportunity, but Utilization Growth has Slowed, BofA Says - marketscreener.com
Procept Biorobotics Shares Slide Amid Downgrade - TipRanks
Procept BioRobotics downgraded to neutral at BofA on slowing utilization - MSN
PROCEPT BioRobotics (NASDAQ:PRCT) Given "Neutral" Rating at Bank of America - MarketBeat
Procept BioRobotics stock downgraded by BofA on slowing growth - Investing.com Australia
PROCEPT BioRobotics Corporation $PRCT Shares Acquired by Thematics Asset Management - MarketBeat
PRCT Downgraded by B of A Securities, Price Target Slashed to $3 - GuruFocus
Wall Street Zen Upgrades PROCEPT BioRobotics (NASDAQ:PRCT) to Hold - MarketBeat
Finanzdaten der Procept Biorobotics Corp-Aktie (PRCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.20%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):